This week's episode covers new developments affecting the US healthcare market including expanded buprenorphine treatment via telemedicine, HHS renewal of the opioid crisis public health emergency, hemodialysis bloodlines added to the shortage list, Optum Rx's shift to cost-based reimbursement, Jefferson Health going out-of-network for Cigna commercial members, cost-effectiveness study of a heart failure management system, blockchain technology enhancing data integrity in FDA submissions, Health Care Service Corporation's $3.7 billion acquisition of Cigna's Medicare Advantage business, FCC Chair warning about merger blocks for companies with DEI policies, delayed telehealth buprenorphine prescribing rule, academic medical centers' concerns about NIH funding cuts, FDA approval of Arbli oral suspension for hypertension, Arizona's Differential Adjusted Payments notice, Governor Newsom's $2.8 billion request for Medi-Cal, CMS terminating four Medicare payment models early, and Aledade and Humana expanding their value-based partnership to rural sites.